Literature DB >> 22521844

Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.

Karin E M Elberse1, Han G J van der Heide, Sandra Witteveen, Ingrid van de Pol, Corrie S Schot, Arie van der Ende, Guy A M Berbers, Leo M Schouls.   

Abstract

The implementation of nationwide pneumococcal vaccination may lead to alterations in the pneumococcal population due to selective pressure induced by the vaccine. To monitor such changes, pneumococcal isolates causing invasive pneumococcal disease (IPD) before (2004-2005, n=1154) and after (2008-2009, n=1190) the implementation of the 7-valent pneumococcal vaccine (PCV7) in 2006 in the national immunization program (NIP) of The Netherlands were characterized by molecular typing using multiple-locus variable number tandem repeat analysis (MLVA) and capsular sequence typing (CST). The IPD incidence after the implementation of PCV7 in children <5 years of age declined, mainly due to an impressive reduction of cases caused by vaccine serotypes. In the age group of patients ≥5 years of age, the overall IPD incidence remained constant, but the IPD incidence due to vaccine serotypes declined in this age cohort as well, indicating herd immunity. IPD incidence of non-vaccine serotypes 1 and 22F isolates increased significantly and a shift in genetic background of the isolates belonging to these serotypes was observed. In general the composition of the pneumococcal population remained similar after the introduction of PCV7. Both before and after introduction of the vaccine several possible capsular switch events were noticed. We found 4 isolates from the pre-vaccination period in which the serotype 19F capsular locus had been horizontally transferred to a different genetic background. Remarkably, none of the 5 post-vaccination isolates in which we observed possible capsule switch belonged to the 19F serotype, possibly due to vaccine induced pressure. In the post-vaccine implementation period we found no evidence for capsular switch of a vaccine serotype to a non-vaccine serotype, indicating that capsular switch is not the main driving force for replacement. This study provides insights into the effects of nationwide vaccination on the pneumococcal population causing IPD.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521844     DOI: 10.1016/j.vaccine.2012.04.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Measurement of pneumococcal polysaccharide vaccine responses for immunodeficiency diagnostics: combined IgG responses compared to serotype specific IgG responses.

Authors:  Willemijn J M Janssen; Andries C Bloem; Perijne Vellekoop; Gertjan J Driessen; Marianne Boes; Joris M van Montfrans
Journal:  J Clin Immunol       Date:  2013-07-24       Impact factor: 8.317

2.  Application of capsular sequence typing (CST) to serotype non-viable Streptococcus pneumoniae isolates from an old collection.

Authors:  G Errico; C Lucarelli; F D'Ambrosio; M Del Grosso; L Ingrosso; A Pantosti; R Camilli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-31       Impact factor: 3.267

3.  Using Standardized Interpretation of Chest Radiographs to Identify Adults with Bacterial Pneumonia--Guatemala, 2007-2012.

Authors:  Jonathan M Wortham; Jennifer Gray; Jennifer Verani; Carmen Lucia Contreras; Chris Bernart; Fabiola Moscoso; Juan Carlos Moir; Emma Lissette Reyes Marroquin; Rigoberto Castellan; Wences Arvelo; Kim Lindblade; John P McCracken
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

4.  Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.

Authors:  Els van Westen; Alienke J Wijmenga-Monsuur; Harry H van Dijken; Jacqueline A M van Gaans-van den Brink; Betsy Kuipers; Mirjam J Knol; Guy A M Berbers; Elisabeth A M Sanders; Nynke Y Rots; Cécile A C M van Els
Journal:  Clin Infect Dis       Date:  2015-04-01       Impact factor: 9.079

5.  Streptococcus pneumoniae Enhances Human Respiratory Syncytial Virus Infection In Vitro and In Vivo.

Authors:  D Tien Nguyen; Rogier Louwen; Karin Elberse; Geert van Amerongen; Selma Yüksel; Ad Luijendijk; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

6.  The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition.

Authors:  Amelieke Jh Cremers; Aldert L Zomer; Jenna F Gritzfeld; Gerben Ferwerda; Sacha Aft van Hijum; Daniela M Ferreira; Joshua R Shak; Keith P Klugman; Jos Boekhorst; Harro M Timmerman; Marien I de Jonge; Stephen B Gordon; Peter Wm Hermans
Journal:  Microbiome       Date:  2014-12-15       Impact factor: 14.650

7.  Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples.

Authors:  Karin Elberse; Suzan van Mens; Amelieke J Cremers; Sabine C A Meijvis; Bart Vlaminckx; Marien I de Jonge; Jacques F Meis; Cornelis Blauwendraat; Ingrid van de Pol; Leo M Schouls
Journal:  BMC Infect Dis       Date:  2015-02-13       Impact factor: 3.090

8.  Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.

Authors:  Matthias Imöhl; Jens Möller; Ralf René Reinert; Stephanie Perniciaro; Mark van der Linden; Orhan Aktas
Journal:  BMC Infect Dis       Date:  2015-02-14       Impact factor: 3.090

9.  Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study.

Authors:  Joon Young Song; Jun Yong Choi; Jin Soo Lee; In-Gyu Bae; Young Keun Kim; Jang Wook Sohn; Yu Mi Jo; Won Suk Choi; Jacob Lee; Kyung Hwa Park; Woo Joo Kim; Hee Jin Cheong
Journal:  BMC Infect Dis       Date:  2013-05-04       Impact factor: 3.090

10.  Multi-serotype pneumococcal nasopharyngeal carriage prevalence in vaccine naïve Nepalese children, assessed using molecular serotyping.

Authors:  Rama Kandasamy; Meeru Gurung; Anushil Thapa; Susan Ndimah; Neelam Adhikari; David R Murdoch; Dominic F Kelly; Denise E Waldron; Katherine A Gould; Stephen Thorson; Shrijana Shrestha; Jason Hinds; Andrew J Pollard
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.